• Center on Health Equity & Access
  • Clinical
  • Health Care Cost
  • Health Care Delivery
  • Insurance
  • Policy
  • Technology
  • Value-Based Care

IVI to Hold Second Methods Summit to Drive Patient-Centered Value Assessment

Article

The summit will address priority patient inputs for comparative effectiveness research and health technology assessments.

Alexandria, VA — April 27, 2021 — The Innovation and Value Initiative (IVI), an independent nonprofit research organization dedicated to advancing patient-centric value assessment, today announced it will convene the second annual Methods Summit, a multi-stakeholder event to drive consensus on priority patient inputs, methods, and research that more fully represent the patient perspective in comparative effectiveness research and economic evaluations of health care interventions.

The program, Designing Equitable Measures and Methods for Patient Priorities in Healthcare Value Assessment, is partially funded through a Patient-Centered Outcomes Research Institute (PCORI) Eugene Washington PCORI Engagement Award (# EAIN-21156). PCORI is an independent, nonprofit organization authorized by Congress in 2010 to fund research that will provide patients, their caregivers, and clinicians with the evidence-based information needed to make better-informed healthcare decisions.

The 3-part virtual summit series will take place in fall 2021. IVI and its partners will engage patient leaders and stakeholders across the health care landscape – including researchers, providers, and payers – to build consensus on how to define, collect, and use data that more fully represent the impacts on patients of disease and treatment options.

For more, read the full release.

Related Videos
Laura Bobolts, PharmD, BCOP, senior vice president of clinical strategy and growth at OncoHealth
Adam Colburn, JD, associate vice president for congressional affairs, AMCP
AMCP Recap 2025
Andrew Evens, DO
Screenshot from interview with Andrew Evens, DO
AJMC Q&A with Jason Bellet, Dr Geoffrey Rutledge, and Dan Nardi
Dan Nardi
Sam Peasah, PhD, MBA, RPh, director for the Center of High-Value Health Care at the University of Pittsburgh Medical Center
Caspian Oliai, MD, MS, a medical oncologist and hematologist and medical director of the UCLA Bone Marrow Transplantation Stem Cell Processing Center
Neha Kashalikar, PharmD, director of strategic pharmacy consulting, MassHealth
Related Content
© 2025 MJH Life Sciences
AJMC®
All rights reserved.